2 assets in Developmental And Epileptic Encephalopathy, 13

Therapeutic assets addressing Developmental And Epileptic Encephalopathy, 13, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Nbi-921352 Developmental And Epileptic Encephalopathy, 13	Neurocrine Biosciences	P2	NR ()
Prax-562 Developmental And Epileptic Encephalopathy, 13	Praxis Precision Medicines	P2/3	NR ()